Second Line Chemotherapy | List of Frontiers open access articles

Original Research

Published on 24 Jan 2024

Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer

in Urologic Oncology

Desiree Louise Draeger
Oliver W. Hakenberg

Frontiers in Urology

doi 10.3389/fruro.2023.1198980

2,218 views
2 citations

Original Research

Published on 22 May 2025

Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study

in Thoracic Oncology

Hassan Abdelilah Tafenzi
Farah Choulli
Ismail Essadi
Rhizlane Belbaraka

Frontiers in Oncology

doi 10.3389/fonc.2025.1489327

2,723 views

Original Research

Published on 15 Apr 2020

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided 125I Seed Implantation vs. Second-Line Chemotherapy

in Radiation Oncology

Hao Wang
Jian Lu
Xiao-Ting Zheng
Jun-Hao Zha
Wen-Dong Jing
Yong Wang
Guang-Yu Zhu
Chu-Hui Zeng
Lei Chen
Jin-He Guo

Frontiers in Oncology

doi 10.3389/fonc.2020.00470

3,966 views
20 citations

Case Report

Published on 08 Jul 2022

The Durable Effect of Pyrotinib Plus Trastuzumab and Chemotherapy in HER2-Positive Gastric Cancer With Brain Metastases: A Case Report and Literature Review

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Xinwei Wang
Yun Zeng
Junling Zhang
Mengli Huang
Bijian Yin

Frontiers in Oncology

doi 10.3389/fonc.2022.940263

2,374 views
3 citations

Case Report

Published on 04 Jan 2023

Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report

in Breast Cancer

Aijuan Tian
Huiyun Lv
Wei Liu
Jinbo Zhao
Shanshan Zhao
Kainan Wang
Chen Song

Frontiers in Oncology

doi 10.3389/fonc.2022.1099164

4,398 views
1 citation

PDF-read only

Editorial

Published on 06 Feb 2012

Management of neuroblastoma: a study of first- and second-line chemotherapy responses, a single institution experience

Emmad E. Habib
Amr T. El-Kashef
Ezzat S. Fahmy

Oncology Reviews

doi 10.4081/oncol.2012.e3

Case Report

Published on 28 Apr 2023

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

in Cancer Immunity and Immunotherapy

Jiabao Yang
Pengfei Xing
Yuehong Kong
Meiling Xu
Liyuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1078915

5,144 views
11 citations

Original Research

Published on 03 Feb 2023

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma

in Pediatric Oncology

Aleksandra Wieczorek
Anna Zaniewska-Tekieli
Karoline Ehlert
Katarzyna Pawinska-Wasikowska
Walentyna Balwierz
Holger Lode

Frontiers in Oncology

doi 10.3389/fonc.2023.1082771

13,166 views
23 citations

Original Research

Published on 26 Feb 2025

Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

in Cancer Immunity and Immunotherapy

Danyang Li
Rui Liu
Zhonghua Fu
Fan Yang
Lixia Ma
Yuelu Guo
Miaomiao Cao
Yang Lei
Yimeng Dou
Xuenan Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532460

4,695 views
11 citations

Case Report

Published on 29 Aug 2024

Case report: complete response and long-term survival on third-line immunotherapy in patient with pleural mesothelioma

in Thoracic Oncology

Željka Jurić Čuljak
Snježana Tomić
Kristina Šitum
Tihana Boraska Jelavić

Frontiers in Oncology

doi 10.3389/fonc.2024.1388829

2,195 views

Original Research

Published on 13 Nov 2024

Magnetically driven hydrogel microrobots for enhancing the therapeutic effect of anlotinib on osteosarcoma

in Biomaterials

Haoyu Wang
Haitian Jiang
Yining Tao
Binghui Yang
Jiakang Shen
Haoran Mu
Chongren Wang
Xiyu Yang
Zhengdong Cai
Mu Li

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2024.1409988

2,949 views
1 citation

Case Report

Published on 11 May 2021

Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review

in Cancer Molecular Targets and Therapeutics

Jing Li
Hejun Liang
Jian He
Xin Sui
Yanru Qin

Frontiers in Oncology

doi 10.3389/fonc.2021.639168

3,584 views
6 citations

Case Report

Published on 18 Nov 2024

Long-term survival in metastatic gastric cancer patient with Apatinib plus S-1 maintenance treatment following first-line chemotherapy—case report

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zhen Wang
Hao Li
Yue Guan
Mingshuang Wu
Manqing Hu
Chenchen Fang

Frontiers in Oncology

doi 10.3389/fonc.2024.1478719

1,666 views
1 citation

Original Research

Published on 26 Oct 2022

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Xiao-Yin Zhao
Xin Liu
Wen-Hua Li
Li-Xin Qiu
Ming-Zhu Huang
Chen-Chen Wang
Zhi-Yu Chen
Wen Zhang
Wan-Jing Feng
Wei-Jian Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.911160

2,430 views
4 citations

Case Report

Published on 03 Feb 2025

Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report

in Cancer Immunity and Immunotherapy

Chang Jiang
Shanxian Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1385794

2,482 views
4 citations

Original Research

Published on 06 Aug 2020

Nestin Expression Affects Resistance to Chemotherapy and Clinical Outcome in Small Cell Lung Cancer

in Thoracic Oncology

Kazuki Sone
Ken Maeno
Ayako Masaki
Eiji Kunii
Osamu Takakuwa
Yusuke Kagawa
Akira Takeuchi
Satoshi Fukuda
Takehiro Uemura
Kensuke Fukumitsu

Frontiers in Oncology

doi 10.3389/fonc.2020.01367

4,169 views
15 citations

Articles

Feasibility and effectiveness of second-line chemotherapy with mitomycin C in patients with advanced penile cancer

Second-line chemotherapy rechallenge in lung cancer patients: a Moroccan real-world study

Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided 125I Seed Implantation vs. Second-Line Chemotherapy

The Durable Effect of Pyrotinib Plus Trastuzumab and Chemotherapy in HER2-Positive Gastric Cancer With Brain Metastases: A Case Report and Literature Review

Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report

Management of neuroblastoma: a study of first- and second-line chemotherapy responses, a single institution experience

PD-1 inhibitor combined with radiotherapy and GM-CSF in MSS/pMMR metastatic colon cancer: a case report

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma

Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

Case report: complete response and long-term survival on third-line immunotherapy in patient with pleural mesothelioma

Magnetically driven hydrogel microrobots for enhancing the therapeutic effect of anlotinib on osteosarcoma

Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review

Long-term survival in metastatic gastric cancer patient with Apatinib plus S-1 maintenance treatment following first-line chemotherapy—case report

Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer

Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report

Nestin Expression Affects Resistance to Chemotherapy and Clinical Outcome in Small Cell Lung Cancer